PARTNER Trial

Related by string. * Partner . Partn . partner : Gold Certified Partner . partner Derek Hough . archive partner FPInfomart . Founding Partner . PARTNER . Managing Partner / trialed . trialing . trials . trial . Trials . TRIAL : Phase III clinical trials . Week Premium Trial . placebo controlled clinical trials . Phase III trials . randomized controlled trial . randomized controlled trials * *

Related by context. Frequent words. (Click for all words.) 65 Phase Ib clinical 64 deforolimus 64 multicenter clinical 63 placebo controlled clinical 63 elotuzumab 62 TRITON TIMI 61 randomized Phase III 61 Phase IIa trial 60 phase IIb 60 SWOG 60 Phase 1b trial 60 phase IIa 60 Phase 2a clinical 60 retrospective cohort study 60 Multicenter 60 Phase IIb clinical 59 Amrubicin 59 SABCS 59 double blinded placebo 59 Gynecologic Oncology Group 59 NSABP 59 PRECiSE 59 unblinded 59 prospective randomized controlled 59 Phase 1b 59 Phase III randomized 58 CR# vcMMAE 58 substudy 58 dose escalation trial 58 active comparator 58 SYNTAX 58 label multicenter 58 RTOG 58 Phase 2a trial 58 prospective observational 58 subgroup analyzes 58 SPIRIT III 57 Phase 1b clinical 57 aflibercept 57 glufosfamide 57 ponatinib 57 irbesartan 57 Phase Ib 57 registrational 57 abiraterone acetate 57 Azedra 57 Phase 2b study 57 pertuzumab 57 randomized controlled clinical 57 Radiation Therapy Oncology 57 multicenter randomized double 57 axitinib 57 RRMS patients 57 paclitaxel eluting stent 57 IMC A# 57 secondary efficacy endpoints 57 nab paclitaxel 57 TAXUS Stent 57 ALLHAT 57 Phase 2b clinical 56 PA# [002] 56 GV# [001] 56 Phase 1a 56 Phase IIb 56 pharmacodynamic effects 56 relapsed refractory multiple myeloma 56 Pharmacokinetic 56 romidepsin 56 unblinding 56 composite endpoint 56 phase 2a 56 BLA submission 56 Phase III pivotal 56 Pivotal Trial 56 Thrombolysis 56 events SAEs 56 Neuradiab 55 Acute Myocardial Infarction 55 tanespimycin 55 plus prednisone 55 PROPEL trial 55 tesmilifene 55 metastatic hormone refractory 55 DSMB 55 placebo controlled clinical trials 55 HER2 positive metastatic breast 55 BAY #-# 55 PEG Interferon lambda 55 placebo controlled randomized 55 Pivotal Phase III 55 multicenter randomized 55 pharmacodynamics 55 confirmatory Phase 3 55 confirmatory Phase III 55 neoadjuvant 55 dose regimens 55 liver transplant recipients 55 Apixaban 55 multivariate analyzes 55 RESOLUTE 55 achieved statistical significance

Back to home page